Literature DB >> 11771746

Protein levels of human peroxiredoxin subtypes in brains of patients with Alzheimer's disease and Down syndrome.

S H Kim1, M Fountoulakis, N Cairns, G Lubec.   

Abstract

Human peroxiredoxin (Prx) play important roles in eliminating hydrogen peroxide generated during cellular mechanisms using electrons from thioredoxin (Trx). Oxidative stress induced by reactive oxygen species (ROS) such as hydrogen peroxide has been implicated in the pathogenesis of several neurodegenerative diseases. We applied the proteomic approach to study protein levels of three subtypes of human Prx in brain regions from patients with Alzheimer's disease (AD) and Down Syndrome (DS). Protein levels of Prx-I and Prx-II were significantly increased in AD and DS. Protein levels of Prx-III, a mitochondrial protein, however, were significantly decreased. We conclude that increased protein levels of Prx-I and Prx-II could provide protection against neuronal cell death induced by hydrogen peroxide. Decreased protein levels of Prx-III could be caused by mitochondrial damage shown in AD and DS. Showing upregulated Prx protein levels provides evidence for the involvement of ROS in the pathogenesis of AD and DS.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11771746     DOI: 10.1007/978-3-7091-6262-0_18

Source DB:  PubMed          Journal:  J Neural Transm Suppl        ISSN: 0303-6995


  54 in total

1.  Gastrodia elata Blume (tianma) mobilizes neuro-protective capacities.

Authors:  Arulmani Manavalan; Umamaheswari Ramachandran; Husvinee Sundaramurthi; Manisha Mishra; Siu Kwan Sze; Jiang-Miao Hu; Zhi Wei Feng; Klaus Heese
Journal:  Int J Biochem Mol Biol       Date:  2012-06-03

2.  An investigation of the molecular mechanisms engaged before and after the development of Alzheimer disease neuropathology in Down syndrome: a proteomics approach.

Authors:  Giovanna Cenini; Ada Fiorini; Rukhsana Sultana; Marzia Perluigi; Jian Cai; Jon B Klein; Elizabeth Head; D Allan Butterfield
Journal:  Free Radic Biol Med       Date:  2014-08-20       Impact factor: 7.376

Review 3.  Genetics, transcriptomics, and proteomics of Alzheimer's disease.

Authors:  Andreas Papassotiropoulos; Michael Fountoulakis; Travis Dunckley; Dietrich A Stephan; Eric M Reiman
Journal:  J Clin Psychiatry       Date:  2006-04       Impact factor: 4.384

Review 4.  Mitochondrial thiols in the regulation of cell death pathways.

Authors:  Fei Yin; Harsh Sancheti; Enrique Cadenas
Journal:  Antioxid Redox Signal       Date:  2012-06-11       Impact factor: 8.401

5.  Longitudinal study of differential protein expression in an Alzheimer's mouse model lacking inducible nitric oxide synthase.

Authors:  Michael D Hoos; Brenna M Richardson; Matthew W Foster; Angela Everhart; J Will Thompson; M Arthur Moseley; Carol A Colton
Journal:  J Proteome Res       Date:  2013-09-18       Impact factor: 4.466

Review 6.  Redox proteomics and amyloid β-peptide: insights into Alzheimer disease.

Authors:  D Allan Butterfield; Debra Boyd-Kimball
Journal:  J Neurochem       Date:  2018-11-27       Impact factor: 5.372

Review 7.  Protein S-nitrosylation: role for nitric oxide signaling in neuronal death.

Authors:  Neelam Shahani; Akira Sawa
Journal:  Biochim Biophys Acta       Date:  2011-07-23

8.  The amyloid precursor protein (APP) family members are key players in S-adenosylmethionine formation by MAT2A and modify BACE1 and PSEN1 gene expression-relevance for Alzheimer's disease.

Authors:  Andreas Schrötter; Kathy Pfeiffer; Fouzi El Magraoui; Harald W Platta; Ralf Erdmann; Helmut E Meyer; Rupert Egensperger; Katrin Marcus; Thorsten Müller
Journal:  Mol Cell Proteomics       Date:  2012-08-09       Impact factor: 5.911

Review 9.  Effects of Peroxiredoxin 2 in Neurological Disorders: A Review of its Molecular Mechanisms.

Authors:  Jifei Liu; Gang Su; Juan Gao; Ye Tian; Xiaoyan Liu; Zhenchang Zhang
Journal:  Neurochem Res       Date:  2020-01-30       Impact factor: 3.996

Review 10.  Energy metabolism and inflammation in brain aging and Alzheimer's disease.

Authors:  Fei Yin; Harsh Sancheti; Ishan Patil; Enrique Cadenas
Journal:  Free Radic Biol Med       Date:  2016-05-03       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.